Ulla Møller Weinreich

Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients

Josefin Eklöf, Rikke Sørensen, Truls Sylvan Ingebrigtsen et al. · Clinical Microbiology and Infection · 2019 · 177 citations · Full text

Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure

Line Hust Storgaard, Hans Hockey, Birgitte Schantz Laursen et al. · International Journal of COPD · 2018 · 150 citations · Full text

Return to work after COVID-19 infection – A Danish nationwide registry study

Peter Ascanius Jacobsen, Mikkel Porsborg Andersen, Gunnar Gislason et al. · Public Health · 2022 · 54 citations · Full text

Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole

Malene Risum, Mai-Britt Vestergaard, Ulla Møller Weinreich et al. · Antibiotics · 2021 · 51 citations · Full text

Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial

Dave Singh, Christopher E. Brightling, Klaus F. Rabe et al. · The Lancet Respiratory Medicine · 2024 · 48 citations · Full text

Advanced Lung Disease, Clinical Trials, Tezepelumab Versus Placebo +4